Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 8,196 | 4,270 | 27,185 | 3,521 | 2,857 |
| Gross Profit | 8,196 | 4,270 | 27,185 | 3,521 | 2,857 |
| Operating Expenses | 36,936 | 33,970 | 32,145 | 27,301 | 25,078 |
| Operating Income | -28,740 | -29,700 | -4,960 | -23,780 | -22,221 |
| Other Income | 7,789 | 2,267 | 4,307 | 3,730 | 670 |
| Pre-tax Income | -20,951 | -27,433 | -653 | -20,050 | -21,551 |
| Income Tax | 127 | -170 | 225 | 165 | 231 |
| Net Income Continuous | -21,078 | -27,263 | -878 | -20,215 | -21,782 |
| Net Income | $-21,078 | $-27,263 | $-878 | $-20,215 | $-21,782 |
| EPS Basic Total Ops | -0.24 | -0.23 | -0.01 | -0.24 | -0.30 |
| EPS Basic Continuous Ops | -0.22 | -0.27 | -0.01 | -0.22 | -0.30 |
| EPS Diluted Total Ops | -0.24 | -0.23 | -0.01 | -0.24 | -0.30 |
| EPS Diluted Continuous Ops | -0.22 | -0.27 | -0.01 | -0.22 | -0.30 |
| EBITDA(a) | $-26,857 | $-27,962 | $-3,457 | $-22,644 | $-21,175 |